ask="4.00"
ask_size="300"
average_daily_volume="168540"
bid="1.48"
bid_size="1500"
book_value="0.39"
change="-0.01"
change_from_200_day_moving_average="-0.07"
change_from_50_day_moving_average="-0.04"
change_from_52_week_high="-0.47"
change_From_52_week_low="0.71"
change_in_percent="-0.66%"
close="1.51"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35315000"
high="1.52"
high_52_weeks="1.98"
last_trade_date="2/16/2017"
last_trade_price="1.51"
last_trade_size="2047"
last_trade_time="4:00pm"
low="1.51"
low_52_weeks="0.80"
market_capitalization="102.02M"
moving_average_200_day="1.58"
moving_average_50_day="1.55"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.52"
pe_ratio="N/A"
peg_ratio="-0.54"
percent_change_from_200_day_moving_average="-4.55%"
percent_change_from_50_day_moving_average="-2.51%"
percent_change_from_52_week_high="-23.74%"
percent_change_from_52_week_low="+88.75%"
previous_close="1.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.94"
price_per_sales="1.96"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="7.30"
stock_exchange="NCM"
symbol="BIOL"
volume="56172"
weeks_range_52="0.80 - 1.98"
